Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022
If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2022-10-21
Authors
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
U.S. Department of Health & Human Services
Abstract
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Britton, A., Embi, P. J., Levy, M. E., Gaglani, M., DeSilva, M. B., Dixon, B. E., Dascomb, K., Patel, P., Schrader, K. E., Klein, N. P., Ong, T. C., Natarajan, K., Hartmann, E., Kharbanda, A. B., Irving, S. A., Dickerson, M., Dunne, M. M., Raiyani, C., Grannis, S. J., … Tenforde, M. W. (2022). Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance—VISION Network, 10 States, December 2021—August 2022. Morbidity and Mortality Weekly Report, 71(42), 1335–1342. https://doi.org/10.15585/mmwr.mm7142a4
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Morbidity and Mortality Weekly Report
Rights
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version